CompoAtlas

Senna Tablet

Natural health product licensed in Canada

Licence holder
Yeepharm Canada Inc.
NPN or DIN-HM
80080404
Status
Active licence
Licence date
3 October 2017
Revision date
Not provided
Form
Comprimé
Route of administration
Orale
Application type
Officinale

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Senna alexandrina

Source : Feuille

Extract : Matériel brut sec

Extraction ratio : 10:1

Dry plant equivalent : 860 milligramme

Potency : 8.6 mg Hydroxyanthracene derivatives

86 milligrammeNot calculated

Non-medicinal ingredients

Stéarate de magnésium, Hydroxypropylcellulose, Cellulose microcristalline, Oxyde de fer (Fe2O3), Dioxyde de titane, Glycérine, Amidon de maïs, Hypromellose, Eau purifiée

PopulationAgeQuantity per servingFrequency
Adultes et adolescentsminimum: 11 yearsminimum: 2 Comprimé ; maximum: 3 Comprimé1 Tous les jours

Uses authorised in Canada

(1) (Traditionally used in Herbal Medicine as a) stimulant laxative. (2) (Used in Herbal Medicine for the) short-term relief of occasional constipation. (3) (Used in Herbal Medicine to) promote(s) bowel movement (by direct action on the large intestine).

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80080404

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line